Home / Brimonidine / Czechia
CZ ATC S01EA05 · updated 2 Nov 2026
Brimonidine shortage in Czechia
Is there a Brimonidine shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Brimonidine product is reported short in Czechia. The company estimate for the return is 31 Dec 2026. Main reason: manufacturing problem.
Also short in Canada, Italy, Austria. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | GLABRIN 2MG/ML 2MG/ML OPH GTT SOL 1X5ML anticipated | Pharmaselect International Beteiligungs GmbH, Vídeň | 4 Nov 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.